Connection

Haruhito Sugiyama to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Haruhito Sugiyama has written about Lung Neoplasms.
Haruhito Sugiyama
Connection Strength
0.445
Lung Neoplasms
  1. Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer. Medicine (Baltimore). 2018 Jun; 97(26):e11226.
    View in: PubMed
    Score: 0.216
  2. A prospective, multicenter phase II trial of low-dose erlotinib as maintenance treatment after platinum doublet chemotherapy for advanced non-small cell lung cancer harboring EGFR mutation. Chin Clin Oncol. 2016 Dec; 5(6):77.
    View in: PubMed
    Score: 0.194
  3. [Efficacy of combination therapy with EGFR-TKI and cytotoxic drug in lung adenocarcinoma already treated with EGFR-TKI]. Gan To Kagaku Ryoho. 2012 Feb; 39(2):213-9.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.